Boston-based Vor Biopharma
has completed a $42 million financing round to advance its lead HSC-based candidate
for treating acute myeloid leukaemia (AML) towards the...
India’s Glenmark
Pharmaceuticals plans to spin-off its innovation business into a separate company
based in the US.
Establishing a separate...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkRead more